Fe Pharmaceuticals

Fe Pharmaceuticals is a pharmaceutical startup founded in 2012 with the slogan "Treating diseases where iron is at the core." The company is developing DIBI, a non-toxic, iron-binding copolymer, positioned as a potent (uM MIC), broad-spectrum, antimicrobial agent effective against bacterial and fungal infections, including drug-resistant organisms. DIBI has also shown promise in treating sepsis, inflammatory disorders, and cancer. With 22 published studies characterizing its potential, this water-soluble polymer is deemed ideal for various administration routes. In animal studies, it has demonstrated non-toxic qualities. Additionally, its unique mode of action makes it resistant to microbial resistance, and it also inhibits the development of resistance to co-administered antibiotics. Fe Pharmaceuticals is an intriguing player in the pharmaceutical industry, pioneering a novel approach to combatting infectious diseases.